Revolutionizing technology with a remarkable constant temperature of 18 ºC, our innovations promise unmatched precision and effectiveness.
After a nearly decade-long journey of meticulous research, Qingdao Dmd Medical Technology Co., Ltd. has triumphantly pioneered an extraordinary technological breakthrough. Our dedicated exploration of nearly a thousand raw materials has culminated in cutting-edge constant temperature solutions. Presenting groundbreaking products like constant temperature ice bags, innovative insulin storage cups, advanced constant temperature hot compress bags, and state-of-the-art constant temperature eye bags, all expertly engineered to maintain temperatures from -20 °C to -50 °C. These pioneering technologies have set a new benchmark in their respective industries.
When young ones are faced with a cold or fever, and their temperature remains under 38.5 ºC, physicians often recommend a non-invasive approach like physical cooling. Commonly practiced methods include applying a cold towel or gently wiping the back and armpits with warm water. However, many parents struggle with the nuances of these scientific cooling techniques, seeking an effective yet straightforward solution.
Caution: Baby skin is particularly sensitive, and temperatures below 10 ºC may lead to frostbite. At 10-15 ºC, discomfort and stinging can occur. The ideal cooling point of 18 ºC is recognized as the optimal temperature for physical cooling. Hospitals set the temperature of brain protection equipment to this precise level in intensive care units, ensuring safety and efficacy.
The concept of mild hypothermia brain protection was first introduced by Busto in 1987, defining optimal body surface temperatures between 30 ºC -35 ºC and external cold compress devices ranging from 18 ºC -20 ºC. This revolutionary approach has reignited interest in low-temperature therapy within the medical community. In clinical settings, brain cooling devices are employed to effectively reduce intracranial pressure, alleviate brain edema, protect vulnerable neurons, and mitigate complications and sequelae associated with ischemic hypoxic encephalopathy, marking a significant advancement in therapeutic interventions.
Audited Supplier 
){kind=link}